Xcel Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$473K Buy
394
+6
+2% +$6.13K 0.11% 106
2026
Q1
$357K Buy
388
+12
+3% +$12.2K 0.1% 116
2025
Q4
$404K Sell
376
-2
-0.5% -$1.91K 0.1% 114
2025
Q3
$288K Sell
378
-40
-10% -$29.8K 0.08% 124
2025
Q2
$326K Buy
+418
New +$325K 0.09% 111
2025
Q1
Sell
-509
Closed -$393K 133
2024
Q4
$393K Hold
509
0.11% 95
2024
Q3
$451K Sell
509
-46
-8% -$41.4K 0.13% 89
2024
Q2
$502K Buy
555
+20
+4% +$16K 0.16% 78
2024
Q1
$416K Buy
535
+9
+2% +$6.41K 0.13% 88
2023
Q4
$307K Sell
526
-39
-7% -$22.8K 0.11% 94
2023
Q3
$303K Sell
565
-677
-55% -$349K 0.12% 91
2023
Q2
$582K Buy
1,242
+202
+19% +$84.7K 0.18% 82
2023
Q1
$357K Sell
1,040
-100
-9% -$33.7K 0.13% 103
2022
Q4
$417K Sell
1,140
-42
-4% -$14.9K 0.16% 87
2022
Q3
$382K Hold
1,182
0.14% 91
2022
Q2
$383K Sell
1,182
-2,139
-64% -$642K 0.14% 88
2022
Q1
$951K Buy
3,321
+490
+17% +$126K 0.26% 69
2021
Q4
$782K Buy
2,831
+1,001
+55% +$254K 0.2% 84
2021
Q3
$423K Hold
1,830
0.12% 106
2021
Q2
$420K Buy
1,830
+65
+4% +$13.1K 0.13% 105
2021
Q1
$330K Buy
1,765
+500
+40% +$97.8K 0.12% 102
2020
Q4
$213K Buy
+1,265
New +$189K 0.09% 116
2019
Q2
Sell
-2,340
Closed -$303K 78
2019
Q1
$303K Sell
2,340
-501
-18% -$60.9K 0.31% 62
2018
Q4
$328K Buy
+2,841
New +$317K 0.4% 51

Other funds holding LLY

Xcel Wealth Management's LLY Position: Q2 2026 in Review

Xcel Wealth Management increased its Eli Lilly (LLY) stake by 1.5% in Q2 2026, buying an estimated $6.13K and bringing the position to 394 shares worth $473K. The position accounts for 0.11% of the portfolio, ranked #106.

Xcel Wealth Management first reported a position in LLY in Q4 2018 and has held it in 24 quarters since. The position peaked at $951K in Q1 2022. 4,599 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Xcel Wealth Management held 394 shares of Eli Lilly worth $473K as of Q2 2026.
  • Xcel Wealth Management bought 6 Eli Lilly shares in Q2 2026, an estimated $6.13K.
  • Eli Lilly made up 0.11% of Xcel Wealth Management's portfolio in Q2 2026, its #106 holding.
  • Xcel Wealth Management first reported a position in Eli Lilly in Q4 2018 and has held it in 24 quarters since.
  • Xcel Wealth Management's Eli Lilly position peaked at $951K in Q1 2022.
  • 4,599 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Xcel Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.